Shah N S, Billiar T R
Department of Surgery, University of Pittsburgh, Pennsylvania, USA.
Environ Health Perspect. 1998 Oct;106 Suppl 5(Suppl 5):1139-43. doi: 10.1289/ehp.98106s51139.
Since the discovery that nitric oxide (.NO) accounts for the biologic activity of endothelial-derived relaxing factor, a torrent of research over the last decade has focused on its role, protective or detrimental, in myriad pathophysiologic conditions. Recently, increasing attention has focused on .NO as a possible mediator of the severe hypotension and impaired vasoreactivity characteristic of circulatory failure. Given the ubiquitous and complex role of .NO in biologic systems, inhibition of .NO synthesis in experimental and clinical studies of shock has yielded mixed, sometimes contradictory, results. Although overproduction of .NO in the vasculature may result in systemic vasodilation, .NO synthesis has also clearly been shown to have a beneficial role in regulating organ perfusion and mediating cytotoxicity. In this review, the pathophysiologic importance of .NO in septic shock and hemorrhagic shock is discussed, and novel therapeutic strategies for manipulation of .NO formation are examined.
自从发现一氧化氮(.NO)是内皮源性舒张因子的生物活性成分以来,过去十年间大量研究聚焦于其在多种病理生理状况中所起的作用,无论是保护性的还是有害的。最近,越来越多的关注集中在.NO 作为循环衰竭特征性严重低血压和血管反应性受损的可能介质上。鉴于.NO 在生物系统中普遍且复杂的作用,在休克的实验和临床研究中抑制.NO 合成产生了好坏参半、有时甚至相互矛盾的结果。尽管血管系统中.NO 的过量产生可能导致全身血管舒张,但.NO 合成也已明确显示在调节器官灌注和介导细胞毒性方面具有有益作用。在本综述中,讨论了.NO 在脓毒症休克和失血性休克中的病理生理重要性,并研究了操纵.NO 形成的新型治疗策略。